Amaç: Tüm dünyayı etkisi altına alan koronavirüs hastalığı2019 [coronavirus disease-2019 (COVID-19)] pandemisinin, ancak etkili ve güvenli bir aşılama programı ile kontrol altına alınabileceği düşünülmektedir. Aşılama programının başarılı olmasında, bireylerin aşıya karşı oluşturdukları düşünce ve tutumlar önemlidir. Bu çalışma, bireylerin COVID-19 aşısı hakkında düşünce ve tutumlarının incelenmesi amaçlamaktadır. Gereç ve Yöntemler: Betimleyici tipteki araştırmanın evrenini, Türkiye'de yaşayan 18 yaş üzeri çalışmaya katılmaya gönüllü bireyler oluşturmuştur. Kartopu örnekleme yöntemi kullanılarak, 15.2.2021-15.3.2021 tarihleri arasında 682 bireye ulaşılmıştır. Veriler, 'kişisel bilgi formu' ve 'COVID-19 Aşısına Yönelik Tutumlar Ölçeği' kullanılarak toplanmıştır. Verilerin değerlendirilmesinde SPSS 24.0 programı ile t ve ANOVA, Kruskal-Wallis, Mann-Whitney U ve çoklu regresyon analizi testleri kullanılmıştır. Araştırmanın yürütülebilmesi için etik kurul izni alınmıştır. Bulgular: Bireylerin COVID-19 aşısına yönelik olumlu tutum puan ortalaması 3,20±1,18; olumsuz tutum puan ortalaması ise 3,56±0,88 olduğu bulunmuştur. COVID-19 aşısını yaptırmak isteyenlerin aşıyı yaptırma nedenleri arasında sırayla bilimsel çalışmalara güvenme, aşı yaptırmanın hastalığa yakalanmaktan çok daha az olumsuz etkisinin olduğunu düşünme, aşının bulaşıcı hastalıklardan etkin bir şekilde koruduğunu düşünme, sağlık çalışanlarına güvenme olduğu bulunmuştur. Bireylerin COVID-19 aşısına yönelik olumlu tutumlarının, sosyodemografik ve COVID-19 aşısına yönelik özellikleri üzerindeki düzeyinin %17,3'ünü açıklamaktadır. Sonuç: Bireylerin, COVID-19 aşısına yönelik olumlu tutuma sahip oldukları ve olumsuz tutumlarının düşük olduğu belirlenmiştir. Algı ve tutumlar, hem salgını yönetmede hem de salgınla mücadelede başarıya ulaşmada çok değerlidir.
Anahtar Kelimeler: COVID-19 aşısı; düşünce; tutum; Türkiye
Objective: It is thought that the coronavirus disease2019 (COVID-19) pandemic, which affects the whole world, can only be brought under control with an effective and safe vaccination program. Individuals' thoughts and attitudes towards vaccination are important for the success of the vaccination program. This study, it is aimed to examine the thoughts and attitudes of individuals about the COVID-19 vaccine. Material and Methods: The population of the descriptive type of research consisted of individuals over the age of 18 living in Turkey. By using the snowball sampling method, 682 individuals were reached between 15.2.2021 and 15.3.2021. The data were collected using the 'personal information form' and 'Attitudes Towards the COVID-19 Vaccine Scale'. SPSS 24.0 program, t and ANOVA, Kruskal-Wallis, Mann-Whitney U and multiple regression analysis tests were used to evaluate the data. Ethics committee approval was obtained to conduct the study. Results: Individuals' positive attitude mean score towards COVID-19 vaccine was found to be 3.20±1.18, and negative attitude mean score was found to be 3.56±0.88. It has been found that among the reasons for those who want to get the COVID-19 vaccine, trust in scientific studies, thinking that vaccination has a much less negative effect than getting sick, thinking that the vaccine effectively protects from infectious diseases, and trusting health professionals. It explains 17.3% of the level of the positive attitudes of individuals towards the COVID-19 vaccine on the socio-demographic and characteristics of the COVID-19 vaccine. Conclusion: It has been found that individuals have a positive attitude towards the COVID-19 vaccine and their negative attitude is low. Perceptions and attitudes are very valuable in both managing the epidemic and achieving success in combating the epidemic
Keywords: COVID-19 aşısı; düşünce; tutum; Türkiye
- World Health Organization [İnternet]. © 2021 WHO [Erişim tarihi: 28.3.2021]. Coronavirus Disease (COVID-19) Dashboard. Erişim linki: [Link]
- World Health Organization [İnternet]. © 2021 WHO [Erişim tarihi: 28.3.2021]. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Erişim linki: [Link]
- Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395 (10228):931-4. [Crossref] [PubMed] [PMC]
- World Health Organization [İnternet]. © 2021 WHO [Erişim tarihi: 28.3.2021]. Coronavirus disease (COVID-19) pandemic. Erişim linki: [Link]
- Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305-6. [Crossref] [PubMed]
- Sharpe HR, Gilbride C, Allen E, Belij-Rammerstorfer S, Bissett C, Ewer K, et al. The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world. Immunology. 2020;160(3):223-32. [Crossref] [PubMed] [PMC]
- Centers for Disease Control and Prevention [İnternet]. Erişim tarihi: 28.3.2021. Different COVID-19 Vaccines. Erişim linki: [Link]
- Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194: 245-51. [Crossref] [PubMed] [PMC]
- National Institute of Health [İnternet]. Erişim tarihi: 28.3.2021. Safety and immunogenicity study of 2019-nCoV vaccine (mRNA-1273) for prophylaxis of SARS-CoV-2 infection (COVID-19). Erişim linki: [Link]
- World Health Organization [İnternet]. © 2021 WHO [Erişim tarihi: 1.4.2021]. Draft landscape of COVID-19 candidate vaccines. Erişim linki: [Link]
- COVID-19 Data Portal [İnternet]. Erişim tarihi: 28.3.2021. COVID-19 Türkiye Platformu Aşı ve İlaç Geliştirme Sanal Konferansı Düzenledi. Erişim linki: [Link]
- Rohner-Blanchard G, Caprettini B, Rohner D, Voth HJ. Impact of COVID-19 and health system performance on vaccination hesitancy: Evidence from a two-leg representative survey in the UK. SSRN Electron J. 2020:1-40. [Link]
- Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7): 977-82. [Crossref] [PubMed] [PMC]
- Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020; 38(45):7002-6. [Crossref] [PubMed] [PMC]
- Murphy J, Vallières F, Bentall R, Shevlin M, McBride O, Hartman TK, et al. Preparing for a COVID-19 vaccine: Identifying and psychologically profiling those who are vaccine hesitant or resistant in two general population samples. PsyArXiv. 2020:1-42. [Crossref]
- Faasse K, Newby J. Public perceptions of COVID-19 in Australia: perceived risk, knowledge, health-protective behaviors, and vaccine intentions. Front Psychol. 2020;11: 551004. [Crossref] [PubMed] [PMC]
- COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769-70. [Crossref] [PubMed] [PMC]
- The SAGE Vaccine Hesitancy Working Group. What influences vaccine acceptance: A model of determinants of vaccine hesitancy. 2013:1-5. [Link]
- Akarsu B, Canbay Özdemir D, Ayhan Baser D, Aksoy H, Fidancı İ, Cankurtaran M. While studies on COVID-19 vaccine is ongoing, the public's thoughts and attitudes to the future COVID-19 vaccine. Int J Clin Pract. 2021; 75(4):e13891. [Crossref] [PubMed] [PMC]
- Machida M, Nakamura I, Kojima T, Saito R, Nakaya T, Hanibuchi T, et al. Acceptance of a COVID-19 vaccine in Japan during the COVID-19 pandemic. Vaccines (Basel). 2021;9(3):210. [Crossref] [PubMed] [PMC]
- Geniş B, Gürhan N, Koç M, Geniş Ç, Şirin B, Çırakoğlu OC, et al. Development of perception and attitude scales related with COVID-19 pandemia. Pearson J Soc Sci Humanit. 2020;5(7):306-28. [Link]
- Ward JK, Alleaume C, Peretti-Watel P; COCONEL Group. The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Soc Sci Med. 2020;265:113414. [Crossref] [PubMed] [PMC]
- Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12(1):29. [Crossref] [PubMed] [PMC]
- Chen M, Li Y, Chen J, Wen Z, Feng F, Zou H, et al. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum Vaccin Immunother. 2021;17(7):2279-88. [Crossref] [PubMed] [PMC]
- Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021;39(7):1148-56. [Crossref] [PubMed] [PMC]
- Latkin CA, Dayton L, Yi G, Colon B, Kong X. Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US. PLoS One. 2021;16(2):e0246970. [Crossref] [PubMed] [PMC]
- Shaw J, Stewart T, Anderson KB, Hanley S, Thomas SJ, Salmon DA, et al. Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system. Clin Infect Dis. 2021: ciab054. [PubMed] [PMC]
- Wang K, Wong EL, Ho KF, Cheung AW, Yau PS, Dong D,et al. Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: repeated cross-sectional surveys. Vaccines (Basel). 2021;9(1):62. [Crossref] [PubMed] [PMC]
- Callaghan T, Moghtaderi A, Lueck JA, Hotez PJ, Strych U, Dor A, et al. Correlates and disparities of COVID-19 vaccine hesitancy. SSRN. 2020. [Crossref]
- Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021; 9(2):160. [Crossref] [PubMed] [PMC]
- Dodd RH, Cvejic E, Bonner C, Pickles K, McCaffery KJ; Sydney Health Literacy Lab COVID-19 group. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(3):318-9. [Crossref] [PubMed] [PMC]
- Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020:1-3. [Crossref] [PubMed] [PMC]
- Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, et al. Influences on attitudes regarding potential COVID-19 vaccination in the United States. Vaccines (Basel). 2020;8(4):582. [Crossref] [PubMed] [PMC]
- Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021;1:100012. [Crossref] [PubMed] [PMC]
- Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B. Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med. 2021;270:113684. [Crossref] [PubMed] [PMC]
.: Process List